Selective retina therapy in patients with diabetic maculopathy

被引：16

作者：

Elsner H. ^{[1
,5
]}

Klatt C. ^{[1
]}

Liew S.H.M. ^{[2
]}

Pörksen E. ^{[1
]}

Bunse A. ^{[1
]}

Rudolf M. ^{[1
]}

Brinkmann R. ^{[3
]}

Hamilton R.P. ^{[2
]}

Birngruber R. ^{[3
]}

Laqua H. ^{[4
]}

Roider J. ^{[1
]}

机构：

[1] Klinik für Augenheilkunde, UKSH, Campus Kiel

[2] St. Thomas Hospital, London

[3] Institut für Biomedizinische Optik, Universität Zu Lübeck und Medizinisches Laserzentrum Lübeck GmbH, Lübeck

[4] Klinik für Augenheilkunde, UKSH, Campus Lübeck, Lübeck

[5] Klinik für Augenheilkunde, UKSH, Campus Kiel, 24105 Kiel

来源：

Der Ophthalmologe | 2006年 / 103卷 / 10期

关键词：

Diabetic maculopathy; OCT; Selective Retina Therapy;

D O I：

10.1007/s00347-006-1414-8

中图分类号：

学科分类号：

摘要：

Selective Retina Therapy (SRT) is a new laser treatment that selectively targets the retinal pigmen epithelium (RPE). In this study, we treated 39 patients presenting with nonischemic, focal and focal-diffuse diabetic maculopathy with SRT. In the main. the results indicate that SRT had stabilizing effects on visual acuity, angiographic leakage, lipid exudation, and foveal retinal thickness. SRT is safe and is especially useful for treating pathologies that are located close to the fovea, which cannot be treated with conventional argon laser photocoagulation. © 2006 Springer Medizin Verlag.

引用

页码：856 / 860

页数：4

共 10 条

[1]

Photocoagulation for diabetic macular edema, Arch Ophthalmol, 103, pp. 1796-1806, (1985)

[2]

Klein R., Klein B.E., Moss S.E., Visual impairment in diabetes, Ophthalmology, 91, pp. 1-9, (1984)

[3]

Moss S.E., Klein R., Klein B.E., The 14-year incidence of visual loss in a diabetic population, Ophthalmology, 105, pp. 998-1003, (1998)

[4]

Resnikoff S., Pascolini D., Etya'ale D., Et al., Global data on visual impairment in the year 2002, Bull World Health Organ, 82, pp. 844-851, (2004)

[5]

Roider J., Brinkmann R., Wirbelauer C., Et al., Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: A pilot study, Br J Ophthalmol, 84, pp. 40-47, (2000)

[6]

Roider J., Brinkmann R., Wirbelauer C., Et al., Retinal sparing by selective retinal pigment epithelial photocoagulation, Arch Ophthalmol, 117, pp. 1028-1034, (1999)

[7]

Roider J., Michaud N., Flotte T., Et al., Histology of retinal lesions after continuous irradiation and selective micro-coagulation of the retinal pigment epithelium, Ophthalmologe, 90, pp. 274-278, (1993)

[8]

Schuele G., Elsner H., Framme C., Et al., Optoacoustic real-time dosimetry for selective retina treatment, J Biomed Opt, 10, (2005)

[9]

Yoshimura N., Matsumoto M., Shimizu H., Et al., Photocoagulated human retinal pigment epithelial cells produce an inhibitor of vascular endothelial cell proliferation, Invest Ophthalmol Vis Sci, 36, pp. 1686-1691, (1995)

[10]

Elsner H., Poerksen E., Klatt C., Et al., Selective retina therapy in patients with central serous chorioretinopathie, Graefes Arch Clin Exp Ophthalomol, (2006)

← 1 →